Hospital
The Children's Mercy Hospital
The Children's Mercy Hospital was paid $22.32M by Medicaid between Jan 2018 and Dec 2024, across 140 billing codes. Its largest line is 99283, emergency room visit (moderate) — 26% of everything it billed.
33Billing provider infoTHE CHILDREN'S MERCY HOSPITAL
OVERLAND PARK, KS 66211
OVERLAND PARK, KS 66211
33aNPI1154400232assigned 11/02/2006
33bProvider typeChildren's Hospital
28Total paid$22.32M
24GClaims172,862
24DCodes billed140
24AFirst – last monthJan 2018 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FINUF, ROBERT controls 16+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 36,030 | $6.42M | |
| 2019 | 17,532 | $5.13M | |
| 2020 | 13,814 | $2.98M | |
| 2021 | 22,036 | $374K | |
| 2022 | 23,828 | $1.87M | |
| 2023 | 31,642 | $2.95M | |
| 2024incomplete | 27,980 | $2.58M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 38,256 | 37,650 | $5.75M |
| X4011 | State-specific procedure code | 19% | 4,963 | 4,859 | $4.26M |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 8.5% | 1,751 | 1,720 | $1.89M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 7.2% | 22,891 | 22,550 | $1.61M |
| X4014 | 6.3% | 1,186 | 1,178 | $1.40M | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.8% | 7,506 | 7,411 | $1.06M |
| 95782 | 4.2% | 684 | 672 | $940K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.0% | 9,285 | 9,132 | $895K |
| 87400 | 2.4% | 2,161 | 1,068 | $541K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 2.2% | 2,355 | 2,329 | $482K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.6% | 3,201 | 3,082 | $367K |
| 87430 | 1.3% | 1,186 | 1,169 | $292K |
128 more codes
| X4003 | 1.3% | 3,654 | $285K | |
| 99213 | Doctor's office visit, returning patient (routine) | 1.1% | 44,605 | $247K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.1% | 2,138 | $245K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.1% | 2,609 | $240K |
| 99285 | Emergency room visit (most serious) | <1% | 1,092 | $192K |
| 87081 | <1% | 1,097 | $171K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 937 | $140K |
| 86003 | <1% | 135 | $95K | |
| 76770 | <1% | 489 | $94K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 143 | $87K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 90 | $86K |
| 93325 | <1% | 423 | $73K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,903 | $73K |
| 92523 | <1% | 251 | $53K | |
| 95700 | <1% | 247 | $51K | |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 261 | $49K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 733 | $42K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 99 | $38K |
| G0378 | Hospital observation service, per hour | <1% | 90 | $28K |
| 87631 | <1% | 42 | $28K | |
| 74018 | <1% | 281 | $26K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 657 | $25K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 328 | $25K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 807 | $25K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 64 | $24K |
| 87634 | <1% | 453 | $23K | |
| 81003 | <1% | 349 | $23K | |
| 92567 | <1% | 669 | $23K | |
| 72082 | <1% | 135 | $22K | |
| 92504 | <1% | 442 | $21K | |
| 94664 | <1% | 267 | $20K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,706 | $20K |
| 93320 | <1% | 194 | $19K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 397 | $17K |
| 80076 | <1% | 377 | $14K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 542 | $13K |
| 83516 | <1% | 129 | $12K | |
| 31720 | <1% | 292 | $12K | |
| J3535 | Drug administered through a metered dose inhaler | <1% | 218 | $8K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 186 | $8K |
| 82785 | <1% | 37 | $8K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 283 | $7K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 165 | $7K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 696 | $7K |
| 73100 | <1% | 53 | $7K | |
| 73130 | <1% | 19 | $6K | |
| 95715 | <1% | 28 | $6K | |
| J3490 | Unclassified drugs | <1% | 619 | $5K |
| 69210 | <1% | 31 | $5K | |
| 95117 | <1% | 180 | $5K | |
| 97161 | <1% | 65 | $4K | |
| 72170 | <1% | 94 | $4K | |
| 94010 | <1% | 66 | $3K | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 409 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 48 | $2K |
| 93321 | <1% | 73 | $2K | |
| 80061 | Lipid panel | <1% | 126 | $2K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 49 | $2K |
| 82728 | <1% | 94 | $2K | |
| 86140 | <1% | 295 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 133 | $2K |
| 93304 | <1% | 30 | $2K | |
| 92526 | <1% | 97 | $2K | |
| 84439 | <1% | 116 | $2K | |
| 82784 | <1% | 94 | $1K | |
| 77072 | <1% | 49 | $1K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 15 | $1K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 44 | $1K |
| 85027 | <1% | 116 | $1K | |
| 87420 | <1% | 90 | $1K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 15 | $1K |
| 51701 | <1% | 36 | $1K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 231 | $1K |
| 92610 | <1% | 12 | $1K | |
| 12011 | <1% | 13 | $1K | |
| 81001 | <1% | 198 | $1K | |
| 87077 | <1% | 69 | $997.07 | |
| 73110 | <1% | 15 | $970.05 | |
| 73610 | <1% | 46 | $917.07 | |
| 72081 | <1% | 14 | $841.15 | |
| 85652 | <1% | 158 | $768.88 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 34 | $750.73 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 76 | $735.60 |
| 73630 | <1% | 32 | $711.71 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 18 | $679.16 |
| 87147 | <1% | 73 | $668.27 | |
| 92524 | <1% | 14 | $651.12 | |
| 87186 | <1% | 40 | $636.34 | |
| 73552 | <1% | 13 | $628.37 | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 26 | $596.07 |
| 82570 | <1% | 73 | $546.32 | |
| 84305 | <1% | 22 | $540.72 | |
| 73140 | <1% | 28 | $446.52 | |
| 73590 | <1% | 21 | $425.55 | |
| 83655 | <1% | 34 | $418.31 | |
| 83690 | <1% | 44 | $390.02 | |
| 73090 | <1% | 18 | $387.53 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 145 | $360.46 |
| 81025 | <1% | 42 | $349.01 | |
| 87040 | <1% | 27 | $329.55 | |
| 73562 | <1% | 13 | $297.83 | |
| 86376 | <1% | 12 | $296.59 | |
| 84100 | <1% | 54 | $290.46 | |
| 82977 | <1% | 32 | $284.09 | |
| 87070 | <1% | 30 | $262.12 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 577 | $250.64 |
| 85610 | <1% | 24 | $136.31 | |
| 92587 | <1% | 14 | $131.50 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 200 | $114.67 |
| 82150 | <1% | 12 | $97.56 | |
| J7699 | Noc drugs, inhalation solution administered through dme | <1% | 12 | $83.00 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 59 | $82.98 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 163 | $82.17 |
| 84156 | <1% | 16 | $75.47 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 85 | $69.65 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 154 | $67.78 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 49 | $66.71 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 77 | $55.92 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 48 | $25.97 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 21 | $24.23 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 58 | $18.71 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 52 | $15.69 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 18 | $11.52 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 21 | $1.91 |
| J2704 | Injection, propofol, 10 mg | 0% | 148 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 55 | $0.00 |
| 96040 | 0% | 12 | $0.00 | |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 89 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFINUF, ROBERT (SENIOR VICE PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| The Children's Mercy Hospital | Kansas City, MO | $221.16M |
| The Children's Mercy Hospital | Kansas City, MO | $53.57M |
| The Children's Mercy Hospital | Riverside, MO | $28.27M |
| The Children's Mercy Hospital | Kansas City, MO | $13.40M |
| Children's Mercy-Community Choice Pediatrics | Lees Summit, MO | $8.95M |
| Children's Mercy-Cockerell and Mcintosh Pediatrics, INC | Blue Springs, MO | $6.34M |
| Children's Mercy-Preferred Pediatrics | Lees Summit, MO | $2.92M |
| The Children's Mercy Hospital | Riverside, MO | $2.34M |
| Children's Mercy - Peacock Pediatrics, INC | Saint Joseph, MO | $1.29M |
| Children's Mercy - Cass County Pediatrics & Adolescents | Belton, MO | $1.12M |
| Children's Mercy - Pediatric Partners, INC | Overland Park, KS | $459K |
| The Children's Mercy Hospital | Riverside, MO | $334K |
| Children's Mercy - Redwood Pediatrics | Kansas City, MO | $246K |
| Children's Mercy - Wildwood Pediatrics | Lees Summit, MO | $6K |
| The Childrens Mercy Hospital | Kansas City, MO | $4K |
| The Children's Mercy Hospital | Kansas City, MO | $54.40 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.